Clinical Trial: A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid Tumors

U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07676903) titled 'A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid Tumors' on June 24.

Brief Summary: The study is being conducted to evaluate the safety, tolerability and pharmacokinetics of SHR-4685 in participants with advanced solid tumors.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Solid Tumor

Intervention: DRUG: SHR-4685

SHR-4685, in different doses.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....